X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (149694) 149694
Book Review (17497) 17497
Publication (13617) 13617
Newsletter (3065) 3065
Book Chapter (1406) 1406
Conference Proceeding (782) 782
Dissertation (260) 260
Magazine Article (259) 259
Newspaper Article (253) 253
Government Document (47) 47
Book / eBook (38) 38
Trade Publication Article (10) 10
Web Resource (10) 10
Paper (9) 9
Data Set (6) 6
Reference (5) 5
Transcript (3) 3
Streaming Video (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (123530) 123530
humans (82074) 82074
animals (53917) 53917
male (32947) 32947
female (31676) 31676
mice (25794) 25794
biochemistry & molecular biology (25506) 25506
trans-activators - metabolism (23193) 23193
trans-activators - genetics (20116) 20116
middle aged (17529) 17529
expression (17447) 17447
cell biology (15865) 15865
molecular sequence data (14790) 14790
aged (14174) 14174
adult (13576) 13576
research (12324) 12324
dna-binding proteins - metabolism (11576) 11576
abridged index medicus (11241) 11241
proteins (11229) 11229
base sequence (10748) 10748
gene expression (10689) 10689
signal transduction (10643) 10643
cells, cultured (10627) 10627
cell line (10316) 10316
rats (10301) 10301
tissue plasminogen activator (9989) 9989
plasminogen-activator (9953) 9953
amino acid sequence (9582) 9582
oncology (9559) 9559
gene-expression (9303) 9303
peripheral vascular disease (9235) 9235
hematology (8797) 8797
analysis (8788) 8788
dna-binding proteins - genetics (8331) 8331
mutation (8209) 8209
time factors (8028) 8028
phosphorylation (7962) 7962
stroke (7874) 7874
transcription factors (7748) 7748
transcription factors - metabolism (7641) 7641
promoter regions, genetic (7467) 7467
protein binding (7444) 7444
gene (7411) 7411
cells (7391) 7391
tissue plasminogen activator - therapeutic use (7330) 7330
thrombolytic therapy (7329) 7329
protein (7188) 7188
transcription, genetic (6893) 6893
genetic aspects (6847) 6847
transcription factors - genetics (6708) 6708
fibrinolysis (6570) 6570
trans-activators (6526) 6526
genes (6402) 6402
physiological aspects (6366) 6366
binding sites (6352) 6352
treatment outcome (6307) 6307
transfection (6296) 6296
activation (6271) 6271
trans-activators - physiology (6073) 6073
cancer (6070) 6070
microbiology (6061) 6061
immunology (6049) 6049
clinical neurology (5984) 5984
thrombolysis (5952) 5952
tissue-plasminogen activator (5872) 5872
neurosciences (5797) 5797
article (5750) 5750
apoptosis (5689) 5689
genetics & heredity (5528) 5528
fibrinolytic agents - therapeutic use (5515) 5515
gene expression regulation (5454) 5454
risk factors (5423) 5423
rna, messenger - metabolism (5380) 5380
aged, 80 and over (5371) 5371
pharmacology & pharmacy (5364) 5364
transcriptional activation (5312) 5312
cell line, tumor (5192) 5192
transcription (5150) 5150
immunohistochemistry (5106) 5106
multidisciplinary sciences (5104) 5104
cardiac & cardiovascular systems (5071) 5071
mice, inbred c57bl (5043) 5043
tumor cells, cultured (4989) 4989
in-vivo (4923) 4923
endocrinology & metabolism (4800) 4800
differentiation (4605) 4605
activators (4604) 4604
in-vitro (4478) 4478
activator (4436) 4436
binding (4399) 4399
health aspects (4392) 4392
identification (4358) 4358
developmental biology (4322) 4322
medicine, research & experimental (4277) 4277
inflammation (4202) 4202
kinetics (4187) 4187
blotting, western (4183) 4183
care and treatment (4161) 4161
rna, messenger - genetics (4144) 4144
therapy (4121) 4121
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (20) 20
Online Resources - Online (6) 6
Dentistry (Harry R Abbott) - Stacks (5) 5
UTL at Downsview - May be requested (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UofT at Mississauga - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Dentistry (Harry R Abbott) - Withdrawn (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (147629) 147629
Japanese (1621) 1621
Chinese (1299) 1299
German (998) 998
French (837) 837
Russian (677) 677
Spanish (330) 330
Polish (273) 273
Korean (204) 204
Italian (175) 175
Portuguese (94) 94
Czech (82) 82
Danish (42) 42
Dutch (41) 41
Turkish (41) 41
Hungarian (40) 40
Ukrainian (33) 33
Croatian (19) 19
Norwegian (19) 19
Slovak (14) 14
Swedish (14) 14
Bulgarian (13) 13
Finnish (12) 12
Persian (12) 12
Serbian (12) 12
Romanian (10) 10
Greek (8) 8
Hebrew (7) 7
Indonesian (4) 4
Icelandic (3) 3
Lithuanian (2) 2
Thai (2) 2
Arabic (1) 1
Bosnian (1) 1
Slovenian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain, ISSN 0006-8950, 2012, Volume 135, Issue 11, pp. 3251 - 3264
The neurovascular unit provides a dynamic interface between the circulation and central nervous system. Disruption of neurovascular integrity occurs in... 
traumatic brain injury | matrix metalloproteinase-3 | plasminogen activator inhibitor-1 | tissue plasminogen activator | neurovascular unit | MULTIPLE-SCLEROSIS LESIONS | RECEPTOR-RELATED PROTEIN | TPA | FOCAL CEREBRAL-ISCHEMIA | BARRIER BREAKDOWN | NEUROSCIENCES | CLINICAL NEUROLOGY | STROKE | MATRIX METALLOPROTEINASES | CENTRAL-NERVOUS-SYSTEM | EXPRESSION | BLOOD | Capillary Permeability - physiology | Tissue Plasminogen Activator - metabolism | Brain Injuries - drug therapy | Humans | Middle Aged | Injections, Intraventricular | Capillary Permeability - drug effects | Male | Brain Injuries - metabolism | Brain Injuries - physiopathology | Plasminogen Activator Inhibitor 1 - physiology | Matrix Metalloproteinase Inhibitors - therapeutic use | Brain - metabolism | Dose-Response Relationship, Drug | Brain - blood supply | Tissue Plasminogen Activator - antagonists & inhibitors | Plasminogen Activator Inhibitor 1 - metabolism | Aged, 80 and over | Recovery of Function - physiology | Adult | Disease Models, Animal | Albumins - metabolism | Mice, Inbred C57BL | Plasminogen Activator Inhibitor 1 - administration & dosage | Tissue Plasminogen Activator - administration & dosage | Tissue Plasminogen Activator - physiology | Animals | Brain Injuries - cerebrospinal fluid | Aged | Mice | Matrix Metalloproteinases - metabolism | Index Medicus | Abridged Index Medicus | Stroke | Central nervous system | Membrane permeability | Albumin | Homeostasis | Cerebrospinal fluid | Matrix metalloproteinase | Permeability | Trauma | Plasmin | t-Plasminogen activator | lipoprotein receptors | neuroserpin | plasminogen | Proteolysis | Plasma membranes | Chromium | Serine proteinase | Brain injury | Original
Journal Article
Biochemical Journal, ISSN 0264-6021, 12/2007, Volume 408, Issue 2, pp. 203 - 210
PAI-I and PAI-2 (plasminogen-activator inhibitor types I and 2) are inhibitors of cell surface upA (urokinase plasminogen activator). However, tumour... 
Serpin (serine protease inhibitor) | Plasminogen-activator inhibitor type 2 (PAI-2) | Urokinase plasminogen activator (uPA) | Very-low-density lipoprotein receptor (VLDLr) | Plasminogen-activator inhibitor type 1 (PAI-1) | SYSTEM | very-low-density lipoprotein receptor (VLDLr) | PROTEIN | LDL RECEPTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | plasminogen-activator inhibitor type 1 (PAI-1) | serpin (serine protease inhibitor) | urokinase plasminogen activator (uPA) | COMPLEX-FORMATION | RAP COMPLEX | plasminogen-activator inhibitor type 2 (PAI-2) | DENSITY-LIPOPROTEIN-RECEPTOR | UROKINASE RECEPTOR | BINDING-SITE | LIGAND | Humans | Receptors, Cell Surface - metabolism | Receptors, LDL - metabolism | Plasminogen Activator Inhibitor 2 - physiology | Plasminogen Activator Inhibitor 1 - physiology | Breast Neoplasms - metabolism | Receptors, Urokinase Plasminogen Activator | Breast Neoplasms - chemistry | Plasminogen Activator Inhibitor 1 - chemistry | Plasminogen Activator Inhibitor 1 - metabolism | Urokinase-Type Plasminogen Activator - metabolism | Breast Neoplasms - pathology | Plasminogen Activator Inhibitor 2 - metabolism | Protein Structure, Secondary - physiology | Signal Transduction - physiology | Urokinase-Type Plasminogen Activator - chemistry | Tumor Cells, Cultured | Plasminogen Activator Inhibitor 2 - chemistry | Protein Binding - physiology | Protein Structure, Tertiary - physiology | Index Medicus | uPA, urokinase plasminogen activator | LDLR, low-density lipoprotein receptor | serpin, serine protease inhibitor | uPAR, urokinase plasminogen activator receptor | VLDLr, very-low-density lipoprotein receptor | PAI, plasminogen-activator inhibitor | RAP, receptor-associated protein | RCL, reactive centre loop | ERK, extracellular-signal-regulated kinase | plasminogen-activator inhibitor type 1 (PAI-1) | LRP, low-density lipoprotein receptor-related protein | SPR, surface plasmon resonance | plasminogen-activator inhibitor type 2 (PAI-2)
Journal Article
Journal Article
European Journal of Neuroscience, ISSN 0953-816X, 03/2017, Volume 45, Issue 6, pp. 805 - 815
Glutamate phase shifts the circadian clock in the mammalian suprachiasmatic nucleus ( SCN ) by activating NMDA receptors. Tissue‐type plasminogen activator (... 
urokinase‐type plasminogen activator | circadian rhythms | suprachiasmatic nucleus | tissue‐type plasminogen activator | urokinase-type plasminogen activator | tissue-type plasminogen activator | NEURONAL MIGRATION | CELL-ADHESION MOLECULE | NEUROTROPHIC FACTOR | RECEPTOR | NEUROSCIENCES | IN-VITRO | EXTRACELLULAR-MATRIX | BIOLOGICAL CLOCK | BRAIN | GENE-FUNCTION | Brain-Derived Neurotrophic Factor - genetics | Suprachiasmatic Nucleus - drug effects | Tissue Plasminogen Activator - metabolism | Mice, Inbred C57BL | Plasminogen Inactivators - pharmacology | Male | Tissue Plasminogen Activator - genetics | Suprachiasmatic Nucleus - physiology | Animals | Urokinase-Type Plasminogen Activator - metabolism | Proteolysis | Circadian Clocks | Female | Suprachiasmatic Nucleus - metabolism | Brain-Derived Neurotrophic Factor - metabolism | Mice | Urokinase | Glutamate | Tissue plasminogen activator | Laws, regulations and rules | Suprachiasmatic nucleus | Glutamic acid | Brain | Night | Glutamic acid receptors (ionotropic) | Brain slice preparation | Nuclei | Plasmin | t-Plasminogen activator | Receptors | Casein | Rodents | Entrainment | Inhibition | Biological clocks | Circadian rhythms | Phase transformations | Phase shift | Polyamide-imides | N-Methyl-D-aspartic acid receptors | Circadian rhythm | Mammals | U-Plasminogen activator | Brain-derived neurotrophic factor | Inhibitors | Plasminogen activator inhibitors | TrkB receptors | Glutamatergic transmission | Gates | Index Medicus
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 01/2013, Volume 85, Issue 2, pp. 216 - 222
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2001, Volume 93, Issue 12, pp. 913- - 9120
Journal Article
Biochemistry, ISSN 0006-2960, 03/2017, Volume 56, Issue 12, pp. 1768 - 1784
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 24, pp. 2285 - 2295
Journal Article